Abstract
Three patients developed veno-occlusive disease of the liver (VOD) after allogeneic stem cell transplantation. On the day after diagnosis, N-acetylcysteine (NAC) was given, initially in loading doses and thereafter 50–150 mg/kg/day for 12 to 31 days. The maximum bilirubin levels were 137, 58 and 138 mmol/l in the three patients, respectively. After the introduction of NAC, bilirubin, aspertate aminotransferase, sIL-2 receptor and IL-8 decreased. All three patients achieved normal bilirubin levels and prothrombin times. To conclude, NAC may be useful for treatment of VOD. Bone Marrow Transplantation (2000) 25, 993–996.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Shulman H, Hinterberger W . Hepatic veno-occlusive disease – liver toxicity syndrome after bone marrow transplantation Bone Marrow Transplant 1992 10: 197–214
Jones RJ, Lee KS, Beschorner WE et al. Veno-occlusive disease of the liver following bone marrow transplantation Transplantation 1987 44: 778–783
Holler E, Kolb H, Moller A et al. Increased serum levels of tumor necrosis factor alpha precede major complications of bone marrow transplantation Blood 1990 75: 1011–1016
Remberger M, Ringdén O . Increased levels of soluble IL-2 receptor in veno-occlusive disease of the liver after allogeneic bone marrow transplantation Transplantation 1995 60: 1293–1299
Remberger M, Ringdén O . Serum levels of cytokines after bone marrow transplantation: increased IL-8 levels during severe veno-occlusive disease of the liver Eur J Haematol 1997 59: 254–262
Harrison PM, Keays R, Bray GP et al. Improved outcome of paracetamol-induced fulminant hepatic failure by late administration of acetylcysteine Lancet 1990 335: 1572–1573
Colombo AA, Ranheim EA, Fong T, Kipps TJ . CD40 signaling in B cells involves reactive oxygen intermediates and induces activation of NF-kB Blood 1994 84: (Suppl. 1) 511 (Abstr. 2029)
Ringdén O, Remberger M, Persson U et al. Similar incidence of graft-versus-host disease using HLA-A, -B and -DR identical unrelated bone marrow donors as with HLA-identical siblings Bone Marrow Transplant 1995 15: 619–625
Ringdén O, Wennberg L, Ericzon B-G et al. Alteplase for hepatic veno-occlusive disease after bone marrow transplantation Lancet 1992 340: 546–547
Hägglund H, Ringdén O, Ericzon BG et al. Treatment of hepatic veno-occlusive disease with recombinant human tissue plasminogen activator or orthotopic liver transplantation after allogeneic bone marrow transplantation Transplantation 1996 62: 1076–1080
Bonanomi L, Gazzaniga A . Toxicological, pharmacokinetic and metabolic studies on acetylcysteine Eur J Respir Dis 1980 111: 45–51
Sekharam M, Trotti A, Cunnick JM, Wu J . Suppression of fibroblast cell cycle phase by N-acetylcysteine Toxicol Appl Pharmacol 1998 149: 210–216
Hägglund H, Remberger M, Klaesson S et al. Norethisterone treatment, a major risk-factor for veno-occlusive disease of the liver after allogeneic bone marrow transplantation Blood 1998 92: 4568–4572
Acknowledgements
We thank the staff at the Centre for Allogeneic Stem cell Transplantation for expert patient care. We thank Inger Hammarberg for excellent typing of the manuscript. We thank Zoe and Francis Walsh for scrutinizing the English language. This study was supported by grants from the Swedish Cancer Society (0070-B97-11XBC), the Children’s Cancer Foundation (1997/073), the Swedish Medical Research Council (K98-06X-05971-18B), the FRF Foundation, the Tobias Foundation and the Ellen Bachrach Foundation.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ringdén, O., Remberger, M., Lehmann, S. et al. N-acetylcysteine for hepatic veno-occlusive disease after allogeneic stem cell transplantation. Bone Marrow Transplant 25, 993–996 (2000). https://doi.org/10.1038/sj.bmt.1702387
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1702387
Keywords
This article is cited by
-
A stitch in time saves nine: timely use of N-acetyl cysteine (NAC) for chemotherapy-induced veno-occlusive disease (VOD)—is it a cost-effective alternative?
Supportive Care in Cancer (2022)
-
The effect of N-acetyl-l-cysteine (NAC) on liver toxicity and clinical outcome after hematopoietic stem cell transplantation
Scientific Reports (2018)
-
Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation
Bone Marrow Transplantation (2016)
-
Hepatic Sinusoidal Obstruction Syndrome in a child after chemotherapy for medulloblastoma
Journal of Neuro-Oncology (2010)
-
A prospective randomized study using N-acetyl-L-cysteine for early liver toxicity after allogeneic hematopoietic stem cell transplantation
Bone Marrow Transplantation (2008)